| 2/21/2025 | BKIG | Fitch rates American Medical notes A-
|
| 2/21/2025 | BKIG | S&P gives A- to American Medical notes
|
| 2/21/2025 | BKIG | Moody's gives American Medical notes Baa1
|
| 2/19/2025 | BKIG | S&P ups Boston Scientific
|
| 2/19/2025 | BKIG | Fitch lifts Boston Scientific
|
| 11/20/2024 | BKIG | Moody’s views Boston Scientific, AMS positively
|
| 2/22/2024 | BKIG | S&P assigns American Medical notes BBB+
|
| 2/22/2024 | BKIG | Moody’s gives American Medical notes Baa1
|
| 2/22/2024 | BKIG | Fitch rates American Medical notes BBB+
|
| 12/7/2022 | BKCVIG | S&P upgrades Boston Scientific
|
| 12/6/2022 | BKCVIG | Fitch boosts Boston Scientific
|
| 3/3/2022 | BKCVIG | Moody's gives American Medical notes Baa1
|
| 3/3/2022 | BKCVIG | S&P assigns American Medical notes BBB
|
| 3/3/2022 | BKCVIG | Fitch gives American Medical notes BBB
|
| 3/2/2022 | BKCVIG | S&P turns Boston Scientific view to positive
|
| 2/23/2022 | BKCVIG | Moody's boosts Boston Scientific
|
| 12/6/2021 | BKCVIG | Fitch turns Boston Scientific view to positive
|
| 6/24/2021 | BKIG | Boston Scientific plans some debt for Farapulse acquisition
|
| 5/27/2021 | BKCVIG | S&P boosts Boston Scientific
|
| 5/14/2020 | BKIG | Fitch assigns Boston Scientific notes BBB
|
| 5/14/2020 | BKIG | S&P rates Boston Scientific notes BBB-
|
| 5/14/2020 | BKIG | Moody’s assigns Boston Scientific notes Baa2
|
| 4/21/2020 | BK | Boston Scientific gets $1.25 billion 364-day loan, amends facilities
|
| 2/27/2020 | BK | Boston Scientific enters into $1 billion 364-day term loan
|
| 12/5/2019 | BK | Boston Scientific enters into $700 million 364-day term loan
|
| 10/22/2019 | BKIG | Fitch rates Boston Scientific notes BBB
|
| 8/19/2019 | BK | Boston Scientific draws from term loans to fund BTG acquisition
|
| 2/21/2019 | BK | Boston Scientific to repay term loan with funds from new notes
|
| 2/21/2019 | BKIG | Moody's rates Boston Scientific notes Baa2
|
| 2/21/2019 | BKIG | S&P rates Boston Scientific notes BBB-
|
| 2/21/2019 | BKIG | Fitch rates Boston Scientific notes BBB
|
| 12/21/2018 | BK | Boston Scientific gets $2.75 billion revolver, $2 billion term loans
|
| 11/21/2018 | BKIG | S&P affirms Boston Scientific
|
| 11/20/2018 | BKIG | Boston Scientific plans to incur debt for £3.3 billion buyout of BTG
|
| 8/30/2018 | BKIG | S&P revises Boston Scientific view to positive
|
| 8/21/2018 | BKIG | Fitch gives Boston Scientific loan BBB
|
| 8/21/2018 | BK | Boston Scientific gets $1 billion 364-day term loan via Wells Fargo
|
| 8/16/2018 | BKIG | Fitch affirms Boston Scientific
|
| 2/22/2018 | BKIG | Fitch gives Boston Scientific notes BBB
|
| 2/22/2018 | BKIG | Moody’s rates Boston Scientific notes Baa2
|
| 2/22/2018 | BKIG | S&P rates Boston Scientific notes BBB-
|
| 8/7/2017 | BK | Boston Scientific enters $2.25 billion replacement credit facility
|
| 7/28/2017 | BKIG | S&P: Boston Scientific view to stable
|
| 6/16/2017 | BKIG | Fitch ups Boston Scientific, facility, notes to BBB
|
| 6/13/2017 | BKIG | S&P gives Boston Scientific short-term A-3
|
| 2/10/2017 | BK | Boston Scientific expands revolver to $400 million, extends it to 2019
|
| 12/7/2016 | BKIG | Moody’s raises Boston Scientific to Baa2
|
| 5/7/2015 | BKIG | Moody’s rates Boston Scientific notes Baa3
|
| 5/7/2015 | BKIG | S&P rates Boston Scientific notes BBB-
|
| 5/7/2015 | BKIG | Fitch rates Boston Scientific notes BBB-
|
| 4/16/2015 | BKIG | S&P assigns BBB- to Boston Scientific loans
|
| 4/14/2015 | BK | Boston Scientific gets $2 billion revolver at Libor plus 130 bps
|
| 3/2/2015 | BKIG | S&P: Boston Scientific view now negative
|
| 3/2/2015 | BK | Boston Scientific to obtain new credit facility to fund acquisition
|
| 2/18/2015 | BKIG | S&P affirms Boston Scientific on settlement news
|
| 8/13/2013 | BK | Boston Scientific gets $400 million term loan at Libor plus 150 bps
|
| 8/8/2013 | BKIG | Moody's gives Boston Scientific notes Baa3
|
| 8/8/2013 | BKIG | Fitch rates Boston Scientific notes BBB-
|
| 8/8/2013 | BKIG | S&P rates Boston Scientific notes BBB-
|
| 7/1/2013 | BK | Boston Scientific cuts receivables loans to $350 million, extends term
|
| 7/19/2012 | BKIG | Fitch affirms Boston Scientific
|
| 4/19/2012 | BK | Boston Scientific cuts pricing with new $2 billion five-year revolver
|
| 7/21/2011 | BKHYIG | Fitch lifts Boston Scientific from junk
|
| 3/15/2010 | BKHY | Moody's: No change for Boston Scientific
|
| 2/1/2010 | BKHY | Fitch: Boston Scientific view to stable
|
| 2/1/2010 | BKHY | Moody's affirms Boston Scientific
|
| 12/10/2009 | BKHY | Moody's rates Boston Scientific notes Ba1
|
| 12/10/2009 | BKHY | Fitch rates Boston Scientific notes BB+
|
| 5/19/2009 | BKHY | Fitch affirms Boston Scientific
|
| 3/25/2009 | BKHY | S&P: Boston Scientific view positive
|
| 3/10/2009 | BKHY | Moody's ups Boston Scientific outlook to stable
|
| 2/26/2009 | BK | Boston Scientific amends loan, revising covenants and pricing
|
| 10/7/2008 | BKHY | S&P: Boston Scientific unchanged
|
| 6/4/2008 | BKHY | Fitch: Boston Scientific view stable
|
| 5/9/2008 | BK | Boston Scientific prepays $625 million of term debt
|
| 1/8/2008 | BKHY | S&P: Boston Scientific unchanged
|
| 10/19/2007 | BKHY | S&P: Boston Scientific outlook negative
|
| 8/24/2007 | BKHY | S&P keeps Boston Scientific on watch
|
| 8/23/2007 | BK | Boston Scientific amends loan, extending leverage ratio step-down, revising EBITDA definition
|
| 8/3/2007 | BKHY | S&P lowers Boston Scientific to junk
|
| 8/3/2007 | BKHY | Fitch cuts Boston Scientific to junk
|
